HT
CODX

HAP Trading’s Co-Diagnostics CODX Stock Holding History

HAP Trading’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-955
Closed -$266K – 1990
2020
Q4 		$266K Buy
+955
New +$354K 0.01% 854
2020
Q3 		– Sell
-511
Closed -$263K – 1619
2020
Q2 		$297K Buy
+511
New +$233K 0.02% 573

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

HAP Trading's CODX Position: Q1 2021 in Review

HAP Trading sold out of Co-Diagnostics (CODX) in Q1 2021, closing a stake of 955 shares — an estimated $266K sold.

HAP Trading first reported a position in CODX in Q2 2020 and held it in 2 quarters. The position peaked at $297K in Q2 2020. 95 funds tracked by Wall St. Rank hold CODX as of Q1 2021.

  • HAP Trading reported no remaining Co-Diagnostics position as of Q1 2021 after selling out during the quarter.
  • HAP Trading sold 955 Co-Diagnostics shares in Q1 2021, an estimated $266K.
  • HAP Trading first reported a position in Co-Diagnostics in Q2 2020 and held it in 2 quarters.
  • HAP Trading's Co-Diagnostics position peaked at $297K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.